NYSE:WAT - Waters Stock Price, Forecast & News

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters announced that its Board of Directors has initiated a share buyback plan on Tuesday, April 24th 2018, which permits the company to repurchase $3,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 18.2% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's board believes its shares are undervalued.

Waters Co. (NYSE:WAT) posted its earnings results on Tuesday, October, 29th. The medical instruments supplier reported $2.13 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.13. The medical instruments supplier had revenue of $577.28 million for the quarter, compared to the consensus estimate of $588.35 million. Waters had a return on equity of 77.73% and a net margin of 23.98%. The company's revenue was down .1% on a year-over-year basis. During the same period in the previous year, the business earned $1.92 earnings per share. View Waters' Earnings History.

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Waters.

Waters will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

11 equities research analysts have issued 1 year price targets for Waters' shares. Their forecasts range from $177.00 to $230.00. On average, they expect Waters' stock price to reach $203.71 in the next year. This suggests that the stock has a possible downside of 12.3%. View Analyst Price Targets for Waters.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings and 5 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View Analyst Ratings for Waters.

Headlines about WAT stock have been trending somewhat negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Waters earned a daily sentiment score of -1.4 on InfoTrie's scale. They also gave news stories about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Waters.

Waters saw a increase in short interest in the month of January. As of January 15th, there was short interest totalling 5,780,000 shares, an increase of 5.7% from the December 31st total of 5,470,000 shares. Based on an average trading volume of 444,600 shares, the days-to-cover ratio is presently 13.0 days. Approximately 9.0% of the company's stock are short sold. View Waters' Current Options Chain.

Some companies that are related to Waters include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), BIO-TECHNE (TECH), Bruker (BRKR), Charles River Laboratories Intl. (CRL), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO) and aTyr Pharma (LIFE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Alibaba Group (BABA), Home Depot (HD), Honeywell International (HON), Raytheon (RTN), Verizon Communications (VZ), Cisco Systems (CSCO), Procter & Gamble (PG), CVS Health (CVS) and Northrop Grumman (NOC).

Waters' stock is owned by a number of of institutional and retail investors. Top institutional investors include Marathon Asset Management LLP (0.66%), Boston Trust Walden Corp (0.45%), Bristol John W & Co. Inc. NY (0.43%), Anchor Capital Advisors LLC (0.40%), California Public Employees Retirement System (0.25%) and Fenimore Asset Management Inc. (0.18%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Edward Conard, Elizabeth B Rae, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Institutional Ownership Trends for Waters.

WAT stock was sold by a variety of institutional investors in the last quarter, including Fenimore Asset Management Inc., Assenagon Asset Management S.A., Marathon Asset Management LLP, Copper Rock Capital Partners LLC, Mountain Pacific Investment Advisers Inc. ID, Nisa Investment Advisors LLC, New York State Teachers Retirement System and Boston Trust Walden Corp. Company insiders that have sold Waters company stock in the last year include Edward Conard, Elizabeth B Rae, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View Insider Buying and Selling for Waters.

WAT stock was purchased by a variety of institutional investors in the last quarter, including Anchor Capital Advisors LLC, California Public Employees Retirement System, Campbell & CO Investment Adviser LLC, Nicolet Bankshares Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Birch Capital Management LLC, Douglass Winthrop Advisors LLC and Diversified Trust Co. View Insider Buying and Selling for Waters.

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of WAT stock can currently be purchased for approximately $232.37.

Waters has a market capitalization of $14.97 billion and generates $2.42 billion in revenue each year. The medical instruments supplier earns $593.79 million in net income (profit) each year or $8.29 on an earnings per share basis. Waters employs 7,200 workers across the globe.View Additional Information About Waters.

The official website for Waters is http://www.waters.com/.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]